Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth.
about
Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivoThe Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer ProgressionElevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer.Complement activation by CpG in a human whole blood loop system: mechanisms and immunomodulatory effects.Complement factor H autoantibodies are associated with early stage NSCLC.Complement control protein factor H: the good, the bad, and the inadequate.Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.The role of complement in tumor growthIntegrated analyses of copy number variations and gene differential expression in lung squamous-cell carcinomaA targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancerAnaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.A Therapeutic Antibody for Cancer, Derived from Single Human B Cells.Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.Modulation of protective T cell immunity by complement inhibitor expression on tumor cells.Complement factor H-derived short consensus repeat 18-20 enhanced complement-dependent cytotoxicity of ofatumumab on chronic lymphocytic leukemia cells.Modulation of miR-146a/complement factor H-mediated inflammatory responses in a rat model of temporal lobe epilepsy.Rapid degradation of the complement regulator, CD59, by a novel inhibitorComplement in cancer and cancer immunotherapy.Complement inhibition in cancer therapy.Complementing the Sugar Code: Role of GAGs and Sialic Acid in Complement RegulationBone metastases in lung cancer. Potential novel approaches to therapy.c-Jun and c-Fos regulate the complement factor H promoter in murine astrocytes.Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence.Innate immune mediators in cancer: between defense and resistance.The role of complement inhibitors beyond controlling inflammation.Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity.Serum differential protein identification of Xinjiang Kazakh esophageal cancer patients based on the two-dimensional liquid-phase chromatography and LTQ MS.The complement system in the airway epithelium - an overlooked host defense mechanism and therapeutic target?Complement in cancer: untangling an intricate relationship.
P2860
Q21245712-E235C1B7-44DF-474D-8ED5-1781291164A8Q26750877-7F924943-537A-4718-A464-476300520522Q30316699-BC53C203-97C1-47E8-8B74-9D19AE3FBF97Q33801802-A965C0C5-7B97-4E14-9895-8048C9B5AFF7Q33937882-07B2836A-D0CD-40C4-8C57-6E4B1DFB34B8Q34067107-1A3BDEAF-7370-4B11-A4A3-CD85D7E54E14Q34256060-9A6F2724-E8EF-41A2-BFA4-77880BEBDD81Q35231345-709629A0-22D9-41DA-90B4-DE469776856AQ35987044-52D27CD1-D4E7-43A1-A09C-B435BC07F8E3Q36057882-547F390C-E916-4869-8890-C91D953E3671Q36338990-A92FB28A-B5D4-4FCC-8083-D4A1FC95B6B4Q36913660-1DD9DC7C-272B-42A3-8C3F-2F1D65277681Q37180356-A618561F-0A99-49DB-ADF9-8E68B9F0433DQ37189831-46DD2F60-CD55-473E-8D35-597E121CE1A4Q37377923-183FECFD-A0D6-42EC-BB06-A3BA02F075D0Q37529408-0C14E933-F8C5-4A33-A22E-E6B4E21AF59AQ37727650-7A909745-1212-43A9-B8E3-CE6630C8940FQ37940918-1A605651-6A9B-436A-A09D-0C2ECD38FD1CQ38109340-EB22B2B4-4A72-442E-98DB-008309E21D86Q38362621-16C4F80F-14FF-4F29-BB8B-E57E44F17B07Q38541387-DFAA7C4F-4ED7-4F71-AA6D-8BEB1391A823Q38887260-CF8F62F5-AF75-43F5-96FC-FF866D0CED60Q38916801-7F3B29D7-3AA4-481C-93DC-ECB1DAE51CAFQ38991015-A9156393-3271-4254-8E07-4A233E84D676Q39201843-FD6C248C-66D6-42D7-96B7-A7B95262B0C3Q41966008-10853C77-57B0-4F35-B4B2-A4FA0B1BDE7CQ44037318-C4B39E57-9EBE-46CD-A293-FD3D667C2270Q50021113-2E06460A-AE69-4CA2-9C28-4AD2E9B9AE16Q50049007-79530D19-2E61-425A-B775-0FDF6A7C4BFC
P2860
Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Down-regulation of human compl ...... reduces in vivo tumor growth.
@en
type
label
Down-regulation of human compl ...... reduces in vivo tumor growth.
@en
prefLabel
Down-regulation of human compl ...... reduces in vivo tumor growth.
@en
P2093
P1476
Down-regulation of human compl ...... reduces in vivo tumor growth.
@en
P2093
Daniel Ajona
Leticia Corrales
Luis M Montuenga
Yi-Fan Hsu
P304
P356
10.4049/JIMMUNOL.178.9.5991
P407
P50
P577
2007-05-01T00:00:00Z